SCHEMBL24844751

SCHEMBL24844751

CCOC(=O)/C=C/c1ccc(CO[Si](C)(C)C(C)(C)C)cc1Cl

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.43
ESR1 P03372 1/20 0.41
HSD17B1 P14061 1/20 0.41
HSD17B2 P37059 1/20 0.41
CA12 O43570 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
CA7 P43166 1/20 0.40
CA9 Q16790 1/20 0.40
CA14 Q9ULX7 1/20 0.40
BACE1 P56817 2/20 0.39
FBP1 P09467 1/20 0.39
TTR P02766 1/20 0.38
DPP4 P27487 1/20 0.38
MEN1 O00255 2/20 0.38
MAPT P10636 2/20 0.38
KMT2A Q03164 2/20 0.38
P2RX3 P56373 1/20 0.37
AKR1B10 O60218 1/20 0.37
AKR1B1 P15121 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24845153 0.89 ESR1 (0.50) ESR1HSD17B1HSD17B2CA12CA1
SCHEMBL24845207 0.87 ESR1 (0.41) ESR1HSD17B1HSD17B2CA12CA1
SCHEMBL2231894 0.80 ESR1 (0.43) ESR1BACE1AKR1B10AKR1B1
SCHEMBL24844752 0.80 TTR (0.46) L3MBTL1ESR1HSD17B1HSD17B2CA12
SCHEMBL21507145 0.77 BACE1 (0.64) L3MBTL1ESR1HSD17B1HSD17B2CA12
SCHEMBL29372443 0.77 BACE1 (0.63) ESR1HSD17B1HSD17B2CA12CA1
SCHEMBL2393206 0.77 BACE1 (0.63) ESR1HSD17B1HSD17B2CA12CA1
SCHEMBL28754820 0.77 BACE1 (0.63) ESR1HSD17B1HSD17B2CA12CA1
SCHEMBL13582079 0.75 ESR1 (0.44) ESR1BACE1MEN1KMT2ACYP3A4
SCHEMBL13582083 0.75 ESR1 (0.44) ESR1BACE1MEN1KMT2ACYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023274257-A1 IMIDAZOLE COMPOUND, AND INTERMEDIATE AND APPLICATION THEREOF 诸葛国琴 2023-01-05 WO disclosed